SLE患者外周血IFN-α、NE及MPO表达水平及意义
The Expression and Significance of Serum IFN-α, Serum NE and Serum MPO in Patients with Systemic Lupus Erythematosus
摘要: 目的:检测系统性红斑狼疮(SLE)患者血清干扰素α (IFN-α)、弹性蛋白酶(NE)及髓过氧化物酶(MPO)水平,探讨IFN-α、NE及MPO水平与SLE疾病活动度、血清学指标和临床表现的相关性及IFN-α、中性粒细胞胞外诱捕网(NETs)两者可能存在的关系。方法:采用酶联免疫吸附法(ELISA)测定SLE患者组与健康对照组血清IFN-α、NE及MPO水平,并分析上述指标之间及上述指标与疾病活动度、血清学指标和临床表现的相关性。结果:SLE患者组血清IFN-α、NE、MPO的水平较健康对照组显著增高(p < 0.05),差异有统计学意义;SLE患者组血清IFN-α、NE、MPO的水平均与系统性红斑狼疮活动指数(SLEDAI)评分呈正相关(p < 0.05);SLE患者组血清IFN-α水平与血清补体C3、血红蛋白(Hb)呈负相关(p < 0.05),与红细胞沉降率(ESR)、24 h尿蛋白定量、抗双链DNA抗体(抗ds-DNA抗体)水平呈正相关(p < 0.05),血清MPO水平与抗dsDNA抗体呈正相关(p < 0.05);SLE患者组血清IFN-α水平与血液系统、泌尿系统、关节炎、皮疹、光过敏等临床表现呈正相关(p < 0.05),血清NE水平与皮疹临床表现呈正相关(p < 0.05);结果显示SLE患者组NE、MPO呈正相关(p < 0.05),且IFN-α分别与NE、MPO呈正相关(p < 0.05)。结论:SLE患者组血清IFN-α、NE及MPO水平较健康对照组增高且与SLE中SLEDAI评分、部分血清学指标、临床表现相关,提示IFN-α、NETs水平在SLE发病中发挥作用。同时IFN-α分别与NE、MPO均呈正相关,说明IFN-α与NETs在SLE发病机理中可能具有相关性。
Abstract: Objective: To investigate the levels of serum interferon α (IFN-α), elastase (NE) and myeloperoxidase (MPO) in patients with systemic lupus erythematosus (SLE), to explore the correlation of IFN-α, NE and MPO levels with disease activity, serological indexes and clinical manifestations of SLE and the possible relationship between IFN-α and neutrophil extracellular traps (NETs). Methods: The levels of serum IFN-α, NE and MPO were measured by Enzyme-linked immunoassay (ELISA) method between SLE patients and healthy controls, to analyze the correlation of IFN-α, NE and MPO levels with disease activity, serological indexes and clinical manifestations in SLE patients. Results: The levels of IFN-α, NE and MPO in the SLE patient group were significantly higher than those in the healthy control group (p < 0.05); the levels of IFN-α, NE, MPO in patients with SLE were positively correlated with systemic lupus erythematosus disease activity index (SLEDAI) score; in patients with SLE, the level of serum IFN-α was negatively correlated with serum complement C3 and Hemoglobin (Hb) (p < 0.05), and positively correlated with erythrocyte sedimentation rate (ESR), 24-hour urinary protein and anti-dsDNA antibody level; the level of serum MPO in patients with SLE was positively correlated with anti-dsDNA antibody (p < 0.05); the level of serum IFN-α in patients with SLE was positively correlated with clinical manifestations such as blood system, urinary system, arthritis, rash, photosensitivity (p < 0.05); the level of serum NE in patients with SLE was positively correlated with the clinical manifestations of rash (p < 0.05). The results showed that NE and MPO in SLE patients were positively correlated (p < 0.05), and IFN-α was positively correlated with NE and MPO respectively (p < 0.05). Conclusion: The serum levels of IFN-α, NE and MPO in patients with SLE were higher than healthy control group and positively correlated with SLEDAI score, serological indexes, clinical manifestations, suggesting that the levels of IFN-α and NETs matter in the pathogenesis of SLE. IFN-α was positively correlated with NE and MPO respectively, indicating that IFN-α and NETs may be related in the pathogenesis of SLE.
文章引用:李梦迪. SLE患者外周血IFN-α、NE及MPO表达水平及意义[J]. 临床医学进展, 2020, 10(5): 787-795. https://doi.org/10.12677/ACM.2020.105121

参考文献

[1] Rönnblom, L.E., Alm, G.V. and Oberg, K.E. (1990) Possible Induction of Systemic Lupus Erythematosus by Interferon-Alpha Treatment in a Patient with a Malignant Carcinoid Tumour. Journal of Internal Medicine, 227, 207-210. [Google Scholar] [CrossRef] [PubMed]
[2] Brinkmann, V., Reichard, U., Goosmann, C., et al. (2004) Neutrophil Extracellular Traps Kill Bacteria. Science, 303, 1532-1535. [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会风湿病学分会. 系统性红斑狼疮诊治指南(草案) [J]. 中华风湿病学杂志, 2003, 7(8): 508-513.
[4] Agod, Z., Fekete, T., Budai, M.M., et al. (2017) Regulation of Type I Interferon Responses by Mitochondria-Derived Reactive Oxygen Species in Plasmacytoid Dendritic Cells. Redox Biology, 13, 633-645. [Google Scholar] [CrossRef] [PubMed]
[5] 凌磊, 皮肖冰, 余旸弢, 等. 系统性红斑狼疮患者血清干扰素-α的水平变化及其临床意义[J]. 实用医学杂志, 2016, 32(1): 106-108.
[6] Ronnblom, L. and Leonard, D. (2019) Interferon Pathway in SLE: One Key to Unlocking the Mystery of the Disease. Lupus Science & Medicine, 6, e270. [Google Scholar] [CrossRef] [PubMed]
[7] Gonzalez-Navajas, J.M., Lee, J., David, M., et al. (2012) Immunomodulatory Functions of Type I Interferons. Nature Reviews Immunology, 12, 125-135. [Google Scholar] [CrossRef] [PubMed]
[8] Dall’Era, M.C., Cardarelli, P.M., Preston, B.T., et al. (2005) Type I Interferon Correlates with Serological and Clinical Manifestations of SLE. Annals of the Rheumatic Diseases, 64, 1692-1697. [Google Scholar] [CrossRef] [PubMed]
[9] Rother, N., Pieterse, E., Lubbers, J., et al. (2017) Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis. Frontiers in Immunology, 8, 1136. [Google Scholar] [CrossRef] [PubMed]
[10] Khandpur, R., Carmona-Rivera, C., Vivekanandan-Giri, A., et al. (2013) NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis. Science Translational Medicine, 5, 140r-178r. [Google Scholar] [CrossRef] [PubMed]
[11] Lande, R., Gregorio, J., Facchinetti, V., et al. (2007) Plasmacytoid Dendritic Cells Sense Self-DNA Coupled with Antimicrobial Peptide. Nature, 449, 564-569. [Google Scholar] [CrossRef] [PubMed]